These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 21584555)

  • 1. Growth-factor content of benign and malignant ovaries - a comparison.
    Owens O; Leake R
    Int J Oncol; 1992 Aug; 1(3):353-6. PubMed ID: 21584555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein levels and gene expressions of the epidermal growth factor receptors, HER1, HER2, HER3 and HER4 in benign and malignant ovarian tumors.
    Steffensen KD; Waldstrøm M; Andersen RF; Olsen DA; Jeppesen U; Knudsen HJ; Brandslund I; Jakobsen A
    Int J Oncol; 2008 Jul; 33(1):195-204. PubMed ID: 18575766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progesterone and estradiol stimulate release of epidermal growth factor/transforming growth factor alpha by ovarian tumours in vitro.
    Ridderheim M; Stendahl U; Bäckström T
    Anticancer Res; 1994; 14(6B):2763-8. PubMed ID: 7872715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth factor content in normal and benign ovarian tumours.
    Owens OJ; Leake RE
    Eur J Obstet Gynecol Reprod Biol; 1992 Dec; 47(3):223-8. PubMed ID: 1294409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioligand binding assay determination of epidermal growth factor receptor in ovarian tumours.
    Tomov S; Tzingilev D; Gorchev G; Velkova A; Vesselinova T; Popovska S
    J BUON; 2005; 10(2):241-6. PubMed ID: 17343336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth-factor receptor expression in malignant ovary, benign ovarian-tumors and normal ovary - a comparison.
    Owens O; Leake R
    Int J Oncol; 1993 Feb; 2(2):321-4. PubMed ID: 21573557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of MUC1 in sera of ovarian cancer patients and in sera of patients with benign changes of the ovaries with CA15-3, CA27.29, and PankoMab.
    Jeschke U; Wiest I; Schumacher AL; Kupka M; Rack B; Stahn R; Karsten U; Mayr D; Friese K; Dian D
    Anticancer Res; 2012 May; 32(5):2185-9. PubMed ID: 22593508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Elevated expression of matrix metalloproteinase-9, and fibronectin concentration in recurrent epithelial ovarian cancer].
    Demeter A; Szirmai K; Oláh J; Papp Z; Jeney A
    Orv Hetil; 2004 Aug; 145(31):1617-24. PubMed ID: 15384859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of growth factors in human ovarian carcinomas.
    Bauknecht T; Kiechle M; Bauer G; Siebers JW
    Cancer Res; 1986 May; 46(5):2614-8. PubMed ID: 3008995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of transforming growth factor-alpha, epidermal growth factor and the epidermal growth factor receptor in adenocarcinoma of the prostate and benign prostatic hyperplasia.
    Myers RB; Kudlow JE; Grizzle WE
    Mod Pathol; 1993 Nov; 6(6):733-7. PubMed ID: 7508115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to transforming growth factor alpha (TGFalpha) and epidermal growth factor (EGF) in hepatocytes: lower EGF receptor affinity of TGFalpha is associated with more sustained activation of p42/p44 mitogen-activated protein kinase and greater efficacy in stimulation of DNA synthesis.
    Thoresen GH; Guren TK; Sandnes D; Peak M; Agius L; Christoffersen T
    J Cell Physiol; 1998 Apr; 175(1):10-8. PubMed ID: 9491776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation of betacellulin and heparin-binding EGF-like growth factor in cultured zebrafish ovarian follicle cells by EGF family ligands.
    Tse AC; Ge W
    Comp Biochem Physiol A Mol Integr Physiol; 2009 May; 153(1):13-7. PubMed ID: 19000772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-alpha short-circuits downregulation of the epidermal growth factor receptor.
    Ouyang X; Gulliford T; Huang G; Epstein RJ
    J Cell Physiol; 1999 Apr; 179(1):52-7. PubMed ID: 10082132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are epidermal growth factor and transforming growth factor responsible for pseudoepitheliomatous hyperplasia associated with granular cell tumors?
    Barkan GA; Paulino AF
    Ann Diagn Pathol; 2003 Apr; 7(2):73-7. PubMed ID: 12715330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release of epidermal growth-factor transforming growth-factor-alpha by ovarian-tumors in-vitro.
    Ridderheim M; Andersson A; Cajander S; Tribukait B; Stendahl U; Backstrom T
    Int J Oncol; 1994 Oct; 5(4):781-6. PubMed ID: 21559642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Teratogenic effects of retinoic acid are modulated in mice lacking expression of epidermal growth factor and transforming growth factor-alpha.
    Abbott BD; Best DS; Narotsky MG
    Birth Defects Res A Clin Mol Teratol; 2005 Apr; 73(4):204-17. PubMed ID: 15799028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunocytochemical study of transforming growth factor expression in benign and malignant gliomas.
    Samuels V; Barrett JM; Bockman S; Pantazis CG; Allen MB
    Am J Pathol; 1989 Apr; 134(4):894-902. PubMed ID: 2705509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and prognostic significance of platelet-derived growth factor and its receptors in epithelial ovarian neoplasms.
    Henriksen R; Funa K; Wilander E; Bäckström T; Ridderheim M; Oberg K
    Cancer Res; 1993 Oct; 53(19):4550-4. PubMed ID: 8402626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective cleavage of membrane bound TGFalpha leads to enhanced activation of the EGF receptor in malignant cells.
    Yang H; Jiang D; Li W; Liang J; Gentry LE; Brattain MG
    Oncogene; 2000 Apr; 19(15):1901-14. PubMed ID: 10773880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum insulin-like growth factor (IGF)-I, IGF binding protein (IGFBP)-3, leptin concentrations and insulin resistance in benign and malignant epithelial ovarian tumors in postmenopausal women.
    Serin IS; Tanriverdi F; Yilmaz MO; Ozcelik B; Unluhizarci K
    Gynecol Endocrinol; 2008 Mar; 24(3):117-21. PubMed ID: 18335323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.